Johns Hopkins Medicine scientists have engineered a simplified form of biodegradable nanoparticles designed to instruct the immune system in targeting disease-causing cells.
These nanoparticles facilitate the immune system's recognition and destruction of harmful cells, potentially transforming treatment protocols for various diseases.
The development represents a notable step forward in the integration of nanotechnology with immunotherapy, with implications for future medical applications.